For shareholders in Intertek Group (LSE:ITRK), the big decisions have already been made. The FTSE 100 testing, inspection and certification specialist agreed in June to a final cash offer from Swedish Investment group EQT, and in August its investors voted overwhelmingly to back the deal.
What remains is the slower, more procedural part of a UK takeover: regulatory clearances, a court sanction hearing and, eventually, the removal of one of London's longest-standing quality-assurance names from the stock market. Here is where the deal stands, what shareholders are due to receive, and what could still get in the way before completion.
From rejected approaches to an agreed final offer
EQT's pursuit of Intertek played out over several weeks in the spring. According to the offer announcement, EQT's initial proposal of £51.50 per share on 10 April 2026 was rejected by the board, as were two further indicative proposals. The two sides then reached agreement on a higher price, and on 18 June 2026 an agreed final cash offer was announced.
The bidding vehicle is Isotope Bidco Limited. It is indirectly owned mainly by EQT's flagship EQT X fund, with Luxinva and Mubadala also taking minority stakes alongside it. Intertek's directors unanimously backed the offer, and because it was declared final, EQT cannot raise it except in limited circumstances permitted under the Takeover Code.
The deal is being implemented by a scheme of arrangement, the standard route for UK public takeovers. At the court meeting and general meeting held on 6 August 2026, around 98.7% of votes cast were in favour of the scheme and the related special resolution, a decisive result that removed the biggest single hurdle.
What shareholders are getting
Under the terms, Intertek shareholders are entitled to £60.00 per share in cash from the bidder. On top of that, they retain Intertek's final Dividend for the 2025 financial year of 107.7 pence per share without any reduction, taking the total value to about £61.08 per share.
The offer values Intertek's shares at around £9.3 billion on a cash-consideration basis, or about £9.5 billion including the dividend. The implied Enterprise value is roughly £10.7 billion to £10.9 billion. The price represents a premium of about 62% to the closing share price of £37.70 on 9 April 2026, the day before EQT's first approach, and about 40% to the price on 15 April 2026.
There is one condition worth noting. Any further dividend declared or paid before completion would reduce the cash consideration accordingly, so any interim payout would not add to the total value received. In the meantime, Intertek has kept trading well: its half-year results on 31 July 2026 showed strong first-half growth and reaffirmed the full-year outlook.
Why a buyout firm wants a testing business
Intertek is one of the world's leading testing, inspection and certification businesses. It checks products, commodities, Supply chains and facilities for safety, quality and regulatory compliance across consumer goods, energy, industrials and healthcare, operating through a large global network of laboratories.
That model is attractive to private Capital for several reasons. Revenue is spread across thousands of customers and many industries, much of it recurring and driven by regulation rather than discretionary spending. Cash conversion is typically strong, and the sector has long been consolidated through bolt-on acquisitions, which a private owner can pursue without the scrutiny of quarterly market expectations.
The deal also adds to a wider trend. Intertek is one of a series of UK-listed companies to agree to sell to overseas or private buyers in recent years, reflecting the valuation gap that many bidders see between London and other markets. The transaction marks the latest exit from the London Stock Exchange, and each departure of a FTSE 100 company adds to debate about the depth and appeal of UK stock markets.
What could still derail or delay the deal
With Shareholder approval secured, the main remaining risks are regulatory and legal. The scheme still needs the satisfaction or, where allowed, Waiver of its outstanding conditions, including clearances in the jurisdictions where Intertek operates, before the court can sanction it. Global businesses of this size often require several Merger control and foreign investment approvals, and any of these can take longer than expected or come with conditions attached.
There is also a hard stop in the timetable. The long stop date for the scheme is 11:59pm on 18 June 2027, and if the conditions are not met by then, the deal could lapse unless the parties agree to extend it. A collapse at this stage would be unusual, but it would leave the share price exposed to a fall back towards levels that reflect the standalone Business rather than the offer.
Finally, some shareholders may feel the price undervalues Intertek's long-term prospects, particularly given the growth shown in the first half. That argument, however, has largely been settled by the size of the vote in favour.
Timetable and the steps to delisting
According to the results of the shareholder meetings, the court sanction hearing is expected in the fourth quarter of 2026 or the first quarter of 2027, depending on when the remaining conditions are met. The offer announcement set out the same expected window for completion.
Once the court sanctions the scheme, events move quickly. The last day of dealings in Intertek shares is expected to be the business day after the sanction hearing, with shares suspended and the scheme becoming effective the following day. The listing is due to be cancelled by 8am on the day after that, and shareholders should receive their cash within 14 days of the effective date.
In the meantime, shareholders will be watching for announcements on regulatory approvals, any update on the precise hearing date, and routine holdings disclosures under the Takeover Code. Intertek's own trading updates will matter less to the share price now that the offer is agreed and approved, although they remain a gauge of the business EQT is buying.
Conclusion
Intertek's shareholders have taken the key decision, and the path to completion now rests largely on regulatory approvals and the court process. The terms are fixed at £60 in cash plus the retained 2025 final dividend. The main things to watch are timing and whether any late regulatory hurdle appears before the scheme's long stop date. For the FTSE 100, the eventual exit will mark another high-profile departure from the London market.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...